Evidence map›Paper›PMID 21625217›Full record

ReviewOncogene2011

Mitochondrial respiratory chain complexes: apoptosis sensors mutated in cancer?

A Lemarie, S Grimm

Abstract readReview
PubMed Publisher
In one paragraph

Review in Oncogene, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 114 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. CytochromeSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Exploring the Leukemogenic Potential of GATA-1Antioxidants (Basel, Switzerland) · 2021
    Article
  13. Review
  14. Metformin as a Treatment Strategy for Sjögren's Syndrome.International journal of molecular sciences · 2021
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

A LemarieINSERM U1037-Cancer Research Center of Toulouse (CRCT), Department of Experimental Therapeutics, Institut Claudius Regaud, Toulouse, France. lemarie.anthony@claudiusregaud.fr
S Grimm
Imperial College London · GBUniversité de Toulouse · FR

Funding

Cancer Research UKWellcome Trust
6 · The paper itself

Abstract

Mutations in cancer cells affecting subunits of the respiratory chain (RC) indicate a central role of oxidative phosphorylation for tumourigenesis. Recent studies have suggested that such mutations of RC complexes impact apoptosis induction. We review here the evidence for this hypothesis, which in particular emerged from work on how complex I and II mediate signals for apoptosis. Both protein aggregates are specifically inhibited for apoptosis induction through different means by exploiting with protease activation and pH change, two widespread but independent features of dying cells. Nevertheless, both converge on forming reactive oxygen species for the demise of the cell. Investigations into these mitochondrial processes will remain a rewarding area for unravelling the causes of tumourigenesis and for discovering interference options.

Indexed as

ApoptosisMutationAnimalsDNA, MitochondrialElectron Transport Complex IElectron Transport Complex IIHumansMitochondriaNeoplasmsReactive Oxygen SpeciesDNA, MitochondrialElectron Transport Complex IElectron Transport Complex IIReactive Oxygen Species

Identifiers

PMID21625217
OpenAlexW2053762753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.